A Pilot Study in a Double Blind, Randomized, Placebo-Controlled, Parallel-Group, 16 Week, Trial Design Evaluating the Efficacy and Safety of Levetiracetam 500 mg Tablets in Bid Administration (Daily Dose Ranging From 1000 mg to 3000 mg), in Adults (>18 Years of Ages) Suffering From Chronic Idiopathic Axonal Polyneuropathy.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Levetiracetam (Primary)
- Indications Neuropathic pain; Polyneuropathy
- Focus Therapeutic Use
- 28 Oct 2009 New trial record